{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T18:46:38Z","timestamp":1790793998674,"version":"4.1.0"},"reference-count":67,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","seizure-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seizure"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.seizure.2021.10.020","type":"journal-article","created":{"date-parts":[[2021,10,27]],"date-time":"2021-10-27T08:42:04Z","timestamp":1635324124000},"page":"145-153","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Analysis of trends and factors determining initial antiseizure medication choice for epilepsy in Taiwan"],"prefix":"10.1016","volume":"93","author":[{"given":"Kuo-Liang","family":"Chiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Yu","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang-Po","family":"Hsieh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Nien","family":"Chien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10172","key":"10.1016\/j.seizure.2021.10.020_bib0001","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/S0140-6736(18)32596-0","article-title":"Epilepsy in adults","volume":"393","author":"Thijs","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.seizure.2021.10.020_bib0002","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S1474-4422(19)30411-9","article-title":"The global burden of neurological disorders: translating evidence into policy","volume":"19","author":"Feigin","year":"2020","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.seizure.2021.10.020_bib0003","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1001\/jamaneurol.2017.3949","article-title":"Treatment outcomes in patients with newly diagnosed epilepsy treated with established and new antiepileptic drugs: a 30-year longitudinal cohort study","volume":"75","author":"Chen","year":"2018","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.seizure.2021.10.020_bib0004","first-page":"346","article-title":"[Emotional and behavioral comorbidities and the impact on the quality of life in epilepsy children]","volume":"48","author":"Chen","year":"2010","journal-title":"Zhonghua Er Ke Za Zhi"},{"key":"10.1016\/j.seizure.2021.10.020_bib0005","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/nrd2997","article-title":"Key factors in the discovery and development of new antiepileptic drugs","volume":"9","author":"Bialer","year":"2010","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.seizure.2021.10.020_bib0006","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1684\/j.1950-6945.2004.tb00074.x","article-title":"The choice of antiepileptic drugs in newly diagnosed epilepsy: a national French survey","volume":"6","author":"Semah","year":"2004","journal-title":"Epileptic Disord"},{"key":"10.1016\/j.seizure.2021.10.020_bib0007","first-page":"6","article-title":"Therapeutic strategies in the choice of antiepileptic drugs","volume":"102","author":"Sadzot","year":"2002","journal-title":"Acta Neurol Belg"},{"key":"10.1016\/j.seizure.2021.10.020_bib0008","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.seizure.2015.06.016","article-title":"Choice of the first anti-epileptic drug in elderly patients with newly diagnosed epilepsy: a Finnish retrospective study","volume":"31","author":"Bruun","year":"2015","journal-title":"Seizure"},{"key":"10.1016\/j.seizure.2021.10.020_bib0009","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.eplepsyres.2011.05.003","article-title":"Trends in the use of antiepileptic drugs in Taiwan from 2003 to 2007: a population-based national health insurance study","volume":"96","author":"Hsieh","year":"2011","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.seizure.2021.10.020_bib0010","first-page":"95","article-title":"Comparative persistence of antiepileptic drugs in patients with epilepsy: a STROBE-compliant retrospective cohort study","author":"Lai","year":"2016","journal-title":"Medicine"},{"key":"10.1016\/j.seizure.2021.10.020_bib0011","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1212\/01.WNL.0000123693.82339.FC","volume":"62","author":"French","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.seizure.2021.10.020_bib0012","first-page":"1261","volume":"62","author":"French","year":"2004"},{"issue":"1273","key":"10.1016\/j.seizure.2021.10.020_bib0013","article-title":"NICE guidance on newer drugs for epilepsy in adults","volume":"328","author":"Perucca","year":"2004","journal-title":"Br Med J Publ Group"},{"key":"10.1016\/j.seizure.2021.10.020_bib0014","doi-asserted-by":"crossref","first-page":"260","DOI":"10.5698\/1535-7597.18.4.260","article-title":"Practice guideline update summary: efficacy and tolerability of the new antiepileptic drugs I: treatment of new-onset epilepsy","volume":"18","author":"Kanner","year":"2018","journal-title":"Epilepsy Curr"},{"key":"10.1016\/j.seizure.2021.10.020_bib0015","article-title":"Ethosuximide, sodium valproate or lamotrigine for absence seizures in children and adolescents","volume":"1","author":"Brigo","year":"2021","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.seizure.2021.10.020_bib0016","unstructured":"National_Institute_for_Clinical_Excellence Epilepsies: diagnosis and management. Clinical guideline [CG137], 2012. Last updated May 2021. In, Available: https:\/\/www.nice. org. uk\/guidance\/ cg137 [Accessed 26 May 2021]."},{"key":"10.1016\/j.seizure.2021.10.020_bib0017","doi-asserted-by":"crossref","first-page":"e4792","DOI":"10.7717\/peerj.4792","article-title":"Association of epilepsy and asthma: a population-based retrospective cohort study","volume":"6","author":"Chiang","year":"2018","journal-title":"PeerJ"},{"key":"10.1016\/j.seizure.2021.10.020_bib0018","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1377\/hlthaff.22.3.61","article-title":"Taiwan's new national health insurance program: genesis and experience so far","volume":"22","author":"Cheng","year":"2003","journal-title":"Health Aff"},{"key":"10.1016\/j.seizure.2021.10.020_bib0019","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1080\/17571472.2010.11493315","article-title":"An overview of the healthcare system in Taiwan","volume":"3","author":"Wu","year":"2010","journal-title":"Lond J Prim Care"},{"key":"10.1016\/j.seizure.2021.10.020_bib0020","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1377\/hlthaff.2014.1332","article-title":"Reflections on the 20th anniversary of Taiwan's single-payer National Health Insurance System","volume":"34","author":"Cheng","year":"2015","journal-title":"Health Aff"},{"key":"10.1016\/j.seizure.2021.10.020_bib0021","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/j.1528-1167.2011.03332.x","article-title":"Geographic variation in the age- and gender-specific prevalence and incidence of epilepsy: analysis of Taiwanese National Health Insurance-based data","volume":"53","author":"Chen","year":"2012","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2021.10.020_bib0022","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.eplepsyres.2008.11.018","article-title":"Antiepileptic drug utilization in Taiwan: analysis of prescription using National Health Insurance database","volume":"84","author":"Hsieh","year":"2009","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.seizure.2021.10.020_bib0023","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/1475-9276-12-69","article-title":"The influence of socio-economic status and multimorbidity patterns on healthcare costs: a six-year follow-up under a universal healthcare system","volume":"12","author":"Kuo","year":"2013","journal-title":"Int J Equity Health"},{"key":"10.1016\/j.seizure.2021.10.020_bib0024","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1093\/heapol\/czl037","article-title":"The distribution of net benefits under the National Health Insurance programme in Taiwan","volume":"22","author":"Huang","year":"2007","journal-title":"Health Policy Plan"},{"key":"10.1016\/j.seizure.2021.10.020_bib0025","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s00381-018-3920-9","article-title":"Prevalence and demographic characteristics of comorbid epilepsy in children and adolescents with cerebral palsy: a nationwide population-based study","volume":"35","author":"Chiang","year":"2019","journal-title":"Childs Nerv Syst"},{"key":"10.1016\/j.seizure.2021.10.020_bib0026","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1016\/j.eplepsyres.2014.07.004","article-title":"Prevalence and neuro-psychiatric comorbidities of pediatric epilepsy in Taiwan: a national population-based study","volume":"108","author":"Chiang","year":"2014","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.seizure.2021.10.020_bib0027","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1056\/NEJMoa1009717","article-title":"Carbamazepine-induced toxic effects and HLA-B* 1502 screening in Taiwan","volume":"364","author":"Chen","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.seizure.2021.10.020_bib0028","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1097\/01.fpc.0000199500.46842.4a","article-title":"Genetic susceptibility to carbamazepine-induced cutaneous adverse drug reactions","volume":"16","author":"Hung","year":"2006","journal-title":"Pharmacogenet Genom"},{"key":"10.1016\/j.seizure.2021.10.020_bib0029","doi-asserted-by":"crossref","DOI":"10.1016\/j.yebeh.2019.07.006","article-title":"Treatment patterns in patients with a new diagnosis of epilepsy and psychiatric comorbidities","volume":"99","author":"Kalilani","year":"2019","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.seizure.2021.10.020_bib0030","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1111\/epi.13675","article-title":"What does the US Medicare administrative claims database tell us about initial antiepileptic drug treatment for older adults with new-onset epilepsy?","volume":"58","author":"Martin","year":"2017","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2021.10.020_bib0031","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1111\/bcp.12577","article-title":"Indications of newer and older anti-epileptic drug use: findings from a southern Italian general practice setting from 2005 to 2011","volume":"79","author":"Italiano","year":"2015","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.seizure.2021.10.020_bib0032","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.yebeh.2017.06.008","article-title":"Persistence with antiepileptic drugs in epilepsy patients treated in neurological practices in Germany","volume":"73","author":"Jacob","year":"2017","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.seizure.2021.10.020_bib0033","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.yebeh.2018.04.012","article-title":"Prescription trends and psychiatric symptoms following first receipt of one of seven common antiepileptic drugs in general practice","volume":"84","author":"Josephson","year":"2018","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.seizure.2021.10.020_bib0034","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.seizure.2013.09.007","article-title":"Trends in the first antiepileptic drug prescribed for epilepsy between 2000 and 2010","volume":"23","author":"Pickrell","year":"2014","journal-title":"Seizure"},{"key":"10.1016\/j.seizure.2021.10.020_bib0035","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2019-032551","article-title":"Trends in antiepileptic drug treatment and effectiveness in clinical practice in England from 2003 to 2016: a retrospective cohort study using electronic medical records","volume":"9","author":"Powell","year":"2019","journal-title":"BMJ Open"},{"key":"10.1016\/j.seizure.2021.10.020_bib0036","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.yebeh.2016.07.037","article-title":"Neurologist adherence to clinical practice guidelines and costs in patients with newly diagnosed and chronic epilepsy in Germany","volume":"64","author":"Strzelczyk","year":"2016","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.seizure.2021.10.020_bib0037","doi-asserted-by":"crossref","DOI":"10.1016\/j.eplepsyres.2020.106503","article-title":"Prescription patterns of antiepileptic drugs for adult patients with newly diagnosed focal epilepsy from 2006 to 2017 in Japan","volume":"169","author":"Chen","year":"2021","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.seizure.2021.10.020_bib0038","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.yebeh.2018.05.019","article-title":"Patient characteristics and treatment patterns in patients with newly diagnosed epilepsy: a US database analysis","volume":"85","author":"Faught","year":"2018","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.seizure.2021.10.020_bib0039","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.yebeh.2017.12.026","article-title":"Current state of the union of epilepsy care in the United States: antiepileptic drugs\u2014an introduction to the connectors project","volume":"80","author":"Sirven","year":"2018","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.seizure.2021.10.020_bib0040","first-page":"2914","article-title":"Trends in antiepileptic drugs prescription pattern among patients visiting a tertiary care center","volume":"11","author":"Gayathri","year":"2020","journal-title":"Int J Pharm Sci Res"},{"key":"10.1016\/j.seizure.2021.10.020_bib0041","doi-asserted-by":"crossref","first-page":"215","DOI":"10.5455\/njppp.2020.10.01004202019012020","article-title":"Prescription pattern of antiepileptic drugs in seizure disorder, their adverse reactions and cost analysis: a tertiary care hospital-based study","volume":"10","author":"Vyas","year":"2020","journal-title":"Natl J Physiol Pharm Pharmacol"},{"key":"10.1016\/j.seizure.2021.10.020_bib0042","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/S1607-551X(09)70045-2","article-title":"Oxcarbazepine-induced Stevens-Johnson syndrome: a case report","volume":"25","author":"Lin","year":"2009","journal-title":"Kaohsiung J Med Sci"},{"key":"10.1016\/j.seizure.2021.10.020_bib0043","doi-asserted-by":"crossref","DOI":"10.1016\/j.yebeh.2020.107700","article-title":"Real-world prescribing trends of valproate in women with epilepsy in Korea","volume":"115","author":"Han","year":"2021","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.seizure.2021.10.020_bib0044","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s40263-020-00698-5","article-title":"Pharmacological management of the genetic generalised epilepsies in adolescents and adults","volume":"34","author":"Stephen","year":"2020","journal-title":"CNS Drugs"},{"key":"10.1016\/j.seizure.2021.10.020_bib0045","doi-asserted-by":"crossref","first-page":"95","DOI":"10.3109\/10401230309085675","article-title":"The diverse roles of anticonvulsants in bipolar disorders","volume":"15","author":"Ketter","year":"2003","journal-title":"Ann Clin Psychiatry"},{"key":"10.1016\/j.seizure.2021.10.020_bib0046","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1159\/000119103","article-title":"Epilepsy and dementia in the elderly","volume":"25","author":"Hommet","year":"2008","journal-title":"Dement Geriatr Cognit Disord"},{"key":"10.1016\/j.seizure.2021.10.020_bib0047","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2018.6606","article-title":"Association of prenatal exposure to valproate and other antiepileptic drugs with risk for attention-deficit\/hyperactivity disorder in offspring","volume":"2","author":"Christensen","year":"2019","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.seizure.2021.10.020_bib0048","doi-asserted-by":"crossref","DOI":"10.1136\/archdischild-2015-308278","article-title":"In utero exposure to valproate increases the risk of isolated cleft palate","volume":"101","author":"Jackson","year":"2016","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"10.1016\/j.seizure.2021.10.020_bib0049","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.yebeh.2013.08.001","article-title":"Fetal antiepileptic drug exposure: adaptive and emotional\/behavioral functioning at age 6 years","volume":"29","author":"Cohen","year":"2013","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.seizure.2021.10.020_bib0050","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1001\/jama.2013.2270","article-title":"Prenatal valproate exposure and risk of autism spectrum disorders and childhood autism","volume":"309","author":"Christensen","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.seizure.2021.10.020_bib0051","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.reprotox.2009.02.014","article-title":"Valproic acid in pregnancy: how much are we endangering the embryo and fetus?","volume":"28","author":"Ornoy","year":"2009","journal-title":"Reprod Toxicol"},{"key":"10.1016\/j.seizure.2021.10.020_bib0052","doi-asserted-by":"crossref","first-page":"325","DOI":"10.2165\/00023210-200822040-00004","article-title":"Pregnancy outcome after in utero exposure to valproate","volume":"22","author":"Diav-Citrin","year":"2008","journal-title":"CNS Drugs"},{"key":"10.1016\/j.seizure.2021.10.020_bib0053","doi-asserted-by":"crossref","first-page":"47","DOI":"10.7897\/2230-8407.110110","article-title":"A prospective drug utilization study on anti epileptics at a tertiary care hospital","volume":"11","author":"Manohar Reddy","year":"2020","journal-title":"Int Res J Pharm"},{"key":"10.1016\/j.seizure.2021.10.020_bib0054","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/S0140-6736(07)60460-7","article-title":"The SANAD study of effectiveness of carbamazepine, gabapentin, lamotrigine, oxcarbazepine, or topiramate for treatment of partial epilepsy: an unblinded randomised controlled trial","volume":"369","author":"Marson","year":"2007","journal-title":"Lancet N Am Ed"},{"key":"10.1016\/j.seizure.2021.10.020_bib0055","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/S0140-6736(21)00247-6","article-title":"The SANAD II study of the effectiveness and cost-effectiveness of levetiracetam, zonisamide, or lamotrigine for newly diagnosed focal epilepsy: an open-label, non-inferiority, multicentre, phase 4, randomised controlled trial","volume":"397","author":"Marson","year":"2021","journal-title":"Lancet N Am Ed"},{"key":"10.1016\/j.seizure.2021.10.020_bib0056","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1590\/abd1806-4841.20175070","article-title":"Identifying the incidence of rash, Stevens-Johnson syndrome and toxic epidermal necrolysis in patients taking lamotrigine: a systematic review of 122 randomized controlled trials","volume":"92","author":"Bloom","year":"2017","journal-title":"An Bras Dermatol"},{"key":"10.1016\/j.seizure.2021.10.020_bib0057","first-page":"566","article-title":"Lamotrigine-related skin rashes in adults","volume":"18","author":"Huang","year":"2002","journal-title":"Kaohsiung J Med Sci"},{"key":"10.1016\/j.seizure.2021.10.020_bib0058","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1111\/epi.12074","article-title":"Updated ILAE evidence review of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes","volume":"54","author":"Glauser","year":"2013","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2021.10.020_bib0059","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1111\/ane.13312","article-title":"Evidence-based anti-seizure monotherapy in newly diagnosed epilepsy: a new approach","volume":"142","author":"Compagno Strandberg","year":"2020","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.seizure.2021.10.020_bib0060","unstructured":"Karlsson Lind, L. Antiepileptic drug utilization: need of sex-specific information and decision support. In, 2018."},{"key":"10.1016\/j.seizure.2021.10.020_bib0061","doi-asserted-by":"crossref","first-page":"459","DOI":"10.7861\/clinmedicine.16-5-459","article-title":"Rational prescribing: the principles of drug selection","volume":"16","author":"Maxwell","year":"2016","journal-title":"Clin Med"},{"key":"10.1016\/j.seizure.2021.10.020_bib0062","first-page":"89","article-title":"A study on drug prescription pattern of antiepileptic drugs (AEDs) at a tertiary care hospital in North Eastern India","volume":"68","author":"Jenibemo","year":"2020","journal-title":"J Assoc Phys India"},{"key":"10.1016\/j.seizure.2021.10.020_bib0063","doi-asserted-by":"crossref","first-page":"283","DOI":"10.4103\/ijp.IJP_507_17","article-title":"Prescription pattern of antiepileptic drugs in a tertiary care center of India","volume":"52","author":"Joshi","year":"2020","journal-title":"Indian J Pharmacol"},{"key":"10.1016\/j.seizure.2021.10.020_bib0064","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1212\/01.WNL.0000125185.74276.D2","article-title":"Antiepileptic drug use increases rates of bone loss in older women: a prospective study","volume":"62","author":"Ensrud","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.seizure.2021.10.020_bib0065","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1177\/1759720X11410769","article-title":"Antiepileptics and bone health","volume":"3","author":"Meier","year":"2011","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"10.1016\/j.seizure.2021.10.020_bib0066","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.yebeh.2007.08.002","article-title":"Long-term cognitive and mood effects of zonisamide monotherapy in epilepsy patients","volume":"12","author":"Park","year":"2008","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.seizure.2021.10.020_bib0067","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1046\/j.1528-1157.44.s4.3.x","article-title":"Newer antiepileptic drugs and cognitive issues","volume":"44","author":"Aldenkamp","year":"2003","journal-title":"Epilepsia"}],"container-title":["Seizure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1059131121003472?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1059131121003472?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T02:00:05Z","timestamp":1761012005000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1059131121003472"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":67,"alternative-id":["S1059131121003472"],"URL":"https:\/\/doi.org\/10.1016\/j.seizure.2021.10.020","relation":{},"ISSN":["1059-1311"],"issn-type":[{"value":"1059-1311","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Analysis of trends and factors determining initial antiseizure medication choice for epilepsy in Taiwan","name":"articletitle","label":"Article Title"},{"value":"Seizure","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.seizure.2021.10.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 British Epilepsy Association. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}